Long-term culture of human CD34+ progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34- CD14- and a CD34-CD14+ dendritic cell precursor

Blood

Volumn 93, Issue 7, 1999, Pages 2244-2252

  Arrighi, Jean François ^a   Hauser, Conrad ^a   Chapuis, Bernard ^a   Zubler, Rudolf H ^a   Kindler, Vincent ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FATE; CELL SPECIFICITY; CHICKEN; CYTOKINE PRODUCTION; DENDRITIC CELL; GROWTH REGULATION; HELPER CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

EID: 0033120317     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.7.2244.407a29_2244_2252     Document Type: Article

References (40)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9:271, 1991
2. Hart DNJ: Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 90:3245, 1997
3. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245, 1998
4. Fuchs EJ, Matzinger P: Is cancer dangerous for the immune system? Semin Immunol 8:271, 1996
5. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A: Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782, 1997
6. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steinmann RM, Mellman I: Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787, 1997
7. Kruisbeek AM, Amsen D: Mechanisms underlying T cell tolerance. Curr Opin Immunol 8:233, 1996
8. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62:659, 1996
9. Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH: Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772, 1997
10. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109, 1994
11. Santiago-Schwarz F, Belios E, Diamond B, Carsons SE: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 52:274, 1992
12. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O: Transforming growth factor beta 1, in the presence of granulocyte/ macrophage colony-stimulating factor and interleukin 4 induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 187:961, 1998
13. + bone marrow precursors cultured with c-kit ligand, GM-CSF, and TNFα. J Immunol 154:5851, 1995
14. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNFα cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
15. +TNFα. J Exp Med 184:695, 1996
16. Romani N, Gruner S, Brang D, Klampgen E, Lenz A, Trockenbacher B, Konwalina G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994
17. + hematopoietic progenitor cells. Blood 87:1292, 1996
18. + hematopoietic progenitor cells toward distinct dendritic cell subsets of the Birbeck granules and MIIC-positive Langerhans cells and the interdigitating dendritic cell type. Blood 88:2441, 1996
19. + blood progenitors tor anticancer therapy. Exp Hematol 23:1463, 1995
20. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med 184:1953, 1996
21. Lynch DH, Andreasen A, Maraskovsky E, Whitemore J, Miller RE, Schuh JC: Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat Med 3:625, 1997
22. Maraskovsky E, Roux ER, Teepe M, Braddy S, Lyman SD, Hoek J, McKenna HJ: Dramatic increase in the number of dendritic cells in the peripheral blood of healthy human volunteers treated with Flt3 ligand. Immunol Lett 56:202, 1997 (abstr)
23. Gilboa E, Nair SK, Lyerly HK: Immunotheraphy of cancer with dendritic-cell-based vaccines. Cancer Immunol Immunother 46:82, 1998
24. Reid CD: The biology and clinical applications of dendritic cells. Transfus Med 8:77, 1998
25. Salgaller ML, Tjoa BA, Lodge PA, Ragde H, Kenny G, Boynton A, Murphy GP: Dendritic cell-based immunotherapy of prostate cancer. Crit Rev Immunol 18:101, 1998
26. Nestle OF, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4:328, 1998
27. Hsu FJ, Benike C, Fagnioni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52, 1996
28. + hematopoietic progenitor cells. Blood 86:3413, 1995
29. -) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha. J Immunol 158: 5169, 1997
30. Young CJ, Varma A, DiGiusto D, Backer MP: Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 87:545, 1996
31. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M: Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89:2644, 1997
32. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckman MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
33. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV: A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 170:145, 1994
34. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J Exp Med 182:389, 1995
35. Zhou LJ, Schwarting R, Smith HM, Tedder TF: A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735, 1992
36. Albert ML, Pearce SFA, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N: Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188:1359, 1998
37. Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N: A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 90:3640, 1997
38. Jonuleit H, Khün U, Müller G, Steinbrink K, Paragnik L, Knopp J, Enk AH: Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27:3135, 1997
39. + hematopoietic precursor cells. Blood 87:535, 1996
40. + haematopoietic progenitor cells. Br J Haematol 101:231, 1998